BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 10/01/2003

Pfizer Withdraws FDA Approval for Troglitazone Tablets

The FDA is withdrawing approval of a new drug application for REZULIN (troglitazone) Tablets, submitted by Pfizer, due to the product no longer being commercially available, thereby waiving the opportunity for a public hearing.

Source: Federal Register — Food and Drug AdministrationOpen original release →